Zanubrutinib

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Zanubrutinib and local guidelines before prescribing.

BTK inhibitor

Mechanism

Bruton tyrosine kinase inhibitor.

Uses

CLL, mantle cell lymphoma, Waldenstrom macroglobulinaemia.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Bleeding, neutropenia, infection, AF.

Interactions

CYP3A4 inhibitors.

Contraindications and cautions

Active bleeding

Monitoring

FBC

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

Reduce dose in severe hepatic impairment

Overdose and reversal

Supportive

Special advice

Less AF than ibrutinib; hold around surgery.

More from the textbook: uses, cautions and other points
Where it is discussed in the book